Early Diabetes in Progress

What is prediabetes?

Prediabetes is a state in which blood glucose levels are elevated above normal but not yet in the range used to diagnose Type 2 diabetes.

In clinical terms, it is often defined as:

• fasting glucose: 100–125 mg/dL
• HbA1c: 5.7–6.4%

These thresholds are based on population risk. They do not represent a biological boundary between health and disease.

A transitional state, not a stable condition

Prediabetes is often described as a “risk state.”

In practice, it is better understood as:

👉 ongoing metabolic dysfunction that has not yet reached diagnostic thresholds for diabetes

The underlying processes are already present:

• insulin resistance
• increased liver glucose production
• rising triglycerides
• early liver fat accumulation

These changes do not begin at the moment glucose crosses a diagnostic line. They develop gradually over time.

What is happening in the body

In prediabetes:

• the liver releases more glucose than normal
• insulin becomes less effective
• the pancreas compensates by increasing insulin output

For a period of time, this compensation keeps glucose from rising further.

Over time, this balance becomes unstable.

Why fasting glucose rises

Fasting glucose reflects liver activity.

As metabolic stress increases:

• liver fat accumulates
• insulin signaling weakens
• glucose production becomes less regulated

This leads to:

• gradual elevation of fasting glucose
• progression toward diabetes

The role of insulin resistance

Insulin resistance is central.

It affects:

• muscle (reduced glucose uptake)
• liver (increased glucose output)
• adipose tissue (increased fat release and signaling changes)

These changes are already present in prediabetes.

Relationship to fatty liver

Prediabetes is strongly linked to:

👉 metabolic dysfunction–associated steatotic liver disease (MASLD)

In many individuals:

• liver fat accumulation occurs before glucose rises
• insulin resistance develops in parallel
• fasting glucose rises later

This means:

👉 prediabetes often reflects already established metabolic disease. Glucose rises later—the underlying metabolic disease develops much earlier.

Progression to diabetes

Without intervention, prediabetes frequently progresses to Type 2 diabetes.

Progression is driven by:

• continued metabolic overload
• worsening insulin resistance
• eventual failure of pancreatic compensation

The timeline varies, but the direction is consistent.

Why it matters clinically

Prediabetes is not benign.

It is associated with:

• increased cardiovascular risk
• early vascular changes
• metabolic syndrome
• fatty liver disease

These risks begin before diabetes is formally diagnosed.

Limitations of the definition

Prediabetes is defined by thresholds, but biology is continuous.

Important points:

• glucose levels rise gradually
• metabolic dysfunction precedes diagnosis
• “normal” values may still reflect early disease

The label “prediabetes” may underestimate the underlying process.

What drives prediabetes

The same factors that drive metabolic disease are already active:

• refined carbohydrates
• sugary beverages
• frequent eating patterns
• ultra-processed foods

These create:

• repeated glucose exposure
• high insulin demand
• sustained metabolic stress

Practical interpretation

Prediabetes should be viewed as:

👉 early diabetes in development

It indicates that:

• metabolic regulation is already impaired
• underlying disease processes are active
• progression is likely without change

Bottom line

Prediabetes is not a harmless warning.

It is a measurable stage of metabolic disease characterized by insulin resistance, liver involvement, and rising glucose levels.

The distinction between prediabetes and diabetes is based on thresholds, not on a fundamental difference in biology.

Related pages

Fasting Glucose
HbA1c
Insulin Resistance
Type 2 Diabetes
Metabolic Syndrome